Harvard Business

NOVEMBER 29, 2016

One of the biggest is how to make the transition from legacy technology and analytical competence to more-powerful and sophisticated analytical tools and analysis methodologies. It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.

Data 70

Data Pharmaceuticals Biotechnology Methodologies 70

Harvard Business

FEBRUARY 22, 2017

Methodology This survey was conducted through a partnership between Professor Boris Groysberg and Yo-Jud Cheng from Harvard Business School; WomenCorporateDirectors Foundation, led by Susan Stautberg; Spencer Stuart, led by Julie Hembrock Daum; and independent researcher Deborah Bell.

Telecommunications 72

Telecommunications Biotechnology Real Estate Survey 72

Harvard Business

MAY 10, 2016

In the course of research for our book , we’ve found that this approach also provides an ideal methodology for leaders to identify which M&A deals are most likely to pay off — a disciplined approach that acts as a kind of lens for effectively distinguishing gold from iron pyrite in assessing potential company synergies.

Company 70

Company Strategy Strategy Strategy& 70

Harvard Business

AUGUST 23, 2016

METHODOLOGY. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Maintaining a diversity of political perspectives is an important consideration to ensure that boards are equipped to anticipate and tackle the multitude of challenges that confront companies today.

Telecommunications 70

Telecommunications Biotechnology Survey Healthcare 70